U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820307) titled 'Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants' on Feb. 05.
Brief Summary: The purpose of this study is to evaluate the effect of SUZ on the pharmacokinetics of oral contraceptives.
Study Start Date: Feb. 20
Study Type: INTERVENTIONAL
Condition:
Pain
Intervention:
DRUG: Suzetrigine
Tablets for Oral Administration.
DRUG: DRSP/EE
Combination Tablets for Oral Administration.
DRUG: NGM/EE
Combination Tablets for Oral Administration.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vertex Pharmaceuticals Incorporated
Published by HT Digital Content ...